873 Shares in Solventum Co. (NYSE:SOLV) Purchased by Geneos Wealth Management Inc.

Geneos Wealth Management Inc. bought a new stake in Solventum Co. (NYSE:SOLV) during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The fund bought 873 shares of the company’s stock, valued at approximately $58,000.

Several other hedge funds have also made changes to their positions in SOLV. Copeland Capital Management LLC purchased a new stake in Solventum in the 3rd quarter valued at about $26,000. Modus Advisors LLC acquired a new stake in shares of Solventum during the fourth quarter valued at about $25,000. Mather Group LLC. purchased a new stake in shares of Solventum in the 3rd quarter valued at approximately $27,000. True Wealth Design LLC lifted its holdings in shares of Solventum by 23,550.0% in the 3rd quarter. True Wealth Design LLC now owns 473 shares of the company’s stock worth $33,000 after acquiring an additional 471 shares during the last quarter. Finally, Prospera Private Wealth LLC purchased a new position in shares of Solventum during the 3rd quarter worth approximately $35,000.

Analyst Upgrades and Downgrades

A number of research firms have commented on SOLV. Stifel Nicolaus began coverage on Solventum in a research note on Tuesday, October 8th. They set a “buy” rating and a $82.00 price target on the stock. Piper Sandler increased their target price on Solventum from $71.00 to $75.00 and gave the stock a “neutral” rating in a research note on Friday, November 8th. Morgan Stanley raised their target price on Solventum from $60.00 to $73.00 and gave the company an “equal weight” rating in a report on Monday, November 11th. Finally, Mizuho initiated coverage on shares of Solventum in a research note on Wednesday, December 4th. They set a “neutral” rating and a $70.00 price target on the stock. One analyst has rated the stock with a sell rating, nine have issued a hold rating and one has given a buy rating to the stock. According to data from MarketBeat.com, the company has an average rating of “Hold” and a consensus price target of $68.29.

Solventum Stock Down 1.7 %

Shares of Solventum stock opened at $74.05 on Friday. The business has a 50-day simple moving average of $70.11 and a 200-day simple moving average of $67.03. Solventum Co. has a one year low of $47.16 and a one year high of $96.05. The company has a debt-to-equity ratio of 2.45, a current ratio of 1.15 and a quick ratio of 0.83.

Solventum (NYSE:SOLV) last announced its quarterly earnings data on Thursday, November 7th. The company reported $1.15 EPS for the quarter, missing analysts’ consensus estimates of $1.38 by ($0.23). The business had revenue of $2.08 billion for the quarter, compared to the consensus estimate of $2.05 billion. On average, sell-side analysts forecast that Solventum Co. will post 6.58 earnings per share for the current year.

Solventum Company Profile

Solventum Corporation, a healthcare company, engages in the developing, manufacturing, and commercializing a portfolio of solutions to address critical customer and patient needs. It operates through four segments: Medsurg, Dental Solutions, Health Information Systems, and Purification and Filtration.